Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Monks

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Journal of Science and Medicine in Sport|November 10, 2016
Repeated sprint ability but not neuromuscular fatigue is dependent on short versus long duration recovery time between sprints in healthy malesMichael R Monks, Chris T Compton, Joseph D Yetman, et al.
Neurochemistry International|March 1, 1992
Quantitation of isotypes of D2 receptors using solution hybridizationR P Artymyshyn, K J Ivins, B R Monks, et al.
Molecular Cancer Therapeutics|February 20, 2007
Potent cytotoxicity of the phosphatase inhibitor microcystin LR and microcystin analogues in OATP1B1- and OATP1B3-expressing HeLa cellsNoel R Monks, Shuqian Liu, Yongsheng Xu, et al.
Cancer Chemotherapy and Pharmacology|October 16, 2009
Sensitivity of breast cancer cell lines to recombinant thiaminase IShuqian Liu, Noel R Monks, Jeremiah W Hanes, et al.
British Journal of Cancer|September 5, 2001
Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogueN R Monks, D C Blakey, N J Curtin, et al.
Pediatric Blood & Cancer|April 28, 2017
Characterization of the anti-CD22 targeted therapy, moxetumomab pasudotox, for B-cell precursor acute lymphoblastic leukemiaIchiko Kinjyo, Ksenia Matlawska-Wasowska, Xiaoru Chen, et al.
Journal of Translational Medicine|September 18, 2013
Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumorsJacqueline D Peacock, David Cherba, Kevin Kampfschulte, et al.
Journal of Pharmacological and Toxicological Methods|May 5, 2011
Natural Products Genomics: A novel approach for the discovery of anti-cancer therapeuticsN R Monks, B Li, S Gunjan, et al.
British Journal of Cancer|July 20, 2000
Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT)N R Monks, J A Calvete, N J Curtin, et al.
Molecular and Cellular Biology|November 1, 2011
Loss of Akt1 in mice increases energy expenditure and protects against diet-induced obesityMin Wan, Rachael M Easton, Catherine E Gleason, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Journal of Science and Medicine in Sport|November 10, 2016
Repeated sprint ability but not neuromuscular fatigue is dependent on short versus long duration recovery time between sprints in healthy malesMichael R Monks, Chris T Compton, Joseph D Yetman, et al.
Neurochemistry International|March 1, 1992
Quantitation of isotypes of D2 receptors using solution hybridizationR P Artymyshyn, K J Ivins, B R Monks, et al.
Molecular Cancer Therapeutics|February 20, 2007
Potent cytotoxicity of the phosphatase inhibitor microcystin LR and microcystin analogues in OATP1B1- and OATP1B3-expressing HeLa cellsNoel R Monks, Shuqian Liu, Yongsheng Xu, et al.
Cancer Chemotherapy and Pharmacology|October 16, 2009
Sensitivity of breast cancer cell lines to recombinant thiaminase IShuqian Liu, Noel R Monks, Jeremiah W Hanes, et al.
British Journal of Cancer|September 5, 2001
Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogueN R Monks, D C Blakey, N J Curtin, et al.
Pediatric Blood & Cancer|April 28, 2017
Characterization of the anti-CD22 targeted therapy, moxetumomab pasudotox, for B-cell precursor acute lymphoblastic leukemiaIchiko Kinjyo, Ksenia Matlawska-Wasowska, Xiaoru Chen, et al.
Journal of Translational Medicine|September 18, 2013
Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumorsJacqueline D Peacock, David Cherba, Kevin Kampfschulte, et al.
Journal of Pharmacological and Toxicological Methods|May 5, 2011
Natural Products Genomics: A novel approach for the discovery of anti-cancer therapeuticsN R Monks, B Li, S Gunjan, et al.
British Journal of Cancer|July 20, 2000
Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT)N R Monks, J A Calvete, N J Curtin, et al.
Molecular and Cellular Biology|November 1, 2011
Loss of Akt1 in mice increases energy expenditure and protects against diet-induced obesityMin Wan, Rachael M Easton, Catherine E Gleason, et al.
Pageof 5